Est. 2001·3,000+ placements · six offices · four regions
M&A Activitycurated sourcedetected 2026-07-15 · confidence 95%

Last updated

ResMed: M&A Activity

ResMed divested MatrixCare (software business serving aged care) for US$490 million (~US$700m AUD), a ~33% haircut from the US$750m purchase price in 2018. Divestment signals portfolio rationalization and focus on core sleep health franchise.

Source: GN — ASX:RMD Resmed

Who
ResMed · USA
What happened
ResMed divested MatrixCare (software business serving aged care) for US$490 million (~US$700m AUD), a ~33% haircut from the US$750m purchase price in 2018. Divestment signals portfolio rationalization and focus on core sleep health franchise.
When
2026-07-15
So what
ResMed committed to MatrixCare in 2018 on the thesis that software depth in adjacent care settings would compound its device franchise.

The leadership read

ResMed committed to MatrixCare in 2018 on the thesis that software depth in adjacent care settings would compound its device franchise. That thesis didn't hold. The asset generated roughly 7 cents of earnings for every dollar of revenue, underperformed through the post-Covid staffing collapse in aged care, and now exits at a price that implies roughly eight times earnings: a multiple that tells you buyers weren't bidding for growth. The capital return via buyback rather than reinvestment in software signals that the firm's leadership has made a deliberate judgment: vertical adjacency in care-coordination software is not where its next decade of value compounds. The Noctrix acquisition, closed weeks earlier, points the portfolio squarely toward device-led sleep disorder expansion. This is one of twelve M&A signals we have tracked over the last 90 days. The related set is broad and cross-sector, spanning healthcare, enterprise infrastructure, and consumer assets. The medtech-specific reads are thin in this batch, but the broader pattern is consistent with a portfolio-rationalization cycle: assets acquired in 2017-2019 at peak software multiples are being repriced against a harder post-pandemic operating reality, and acquirers are using proceeds to sharpen rather than diversify. Companies reaching this stage of portfolio concentration in device-led health tend to face rising demand for commercial leadership with deep payer and channel experience, product leadership at the seam between hardware and patient-data platforms, and regulatory operations capable of managing concurrent device-safety events alongside market re-entry by a major competitor. Those pressures are simultaneous here, not sequential.

Market context: Backdrop: a 95.4 (Cool) Talent Market Index (down 5.3 on the month) with Americas activity easing (-16.2pts).

ResMed: 3 signals in the last 90 days; 0.1% of MitchelLake's EMEA signal flow; 9 tracked across 182 days.

MitchelLake in this thematic

Also at ResMed →

More signals across Americas

M&A Activity · Americas

Vection Technologies →

Vection Technologies is poised to acquire all of US-based AR/VR education hardware vendor zSpace via a cash-out merger, valued at US$9.5M (about A$13.6M). The deal is conditional on zSpace reaching an agreed EPA threshold in litigation with EdtechX.

M&A Activity · Americas

Integer Holdings →

KKR has completed its $5.7bn acquisition of medical device manufacturer Integer Holdings, taking the US-listed company private.

M&A Activity · Americas

Corebridge Financial →

Corebridge Financial and Equitable Holdings have named the intended 14-member board for their combined company, ahead of completion of their previously announced merger.

M&A Activity · Americas

Balance Theory →

AI-native cybersecurity investment management platform Balance Theory acquired VectorBlack, an AI decision-intelligence company that provides market intelligence and threat analysis to CISOs. Terms were undisclosed. The deal follows a $19M Series A in July 2026.

M&A Activity · Americas

Wind Point Partners →

Chicago-based Wind Point Partners acquired Chroma Color Corporation, planning buy-and-build expansion and presence in high-growth markets.

M&A Activity · Americas

Nuveen Virginia Quality Municipal Income Fund →

SEC Rule 425 filing (business-combination communication) on a Nuveen closed-end municipal fund, indicating a proposed fund merger or reorganization.

Where this lands in our work

Weekly briefing

Track companies like ResMed — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗